טוען...
A MODEL OF POSTSURGICAL ADVANCED METASTATIC BREAST CANCER MORE ACCURATELY REPLICATES THE CLINICAL EFFICACY OF ANTIANGIOGENIC DRUGS
The failure rate of randomized phase III oncology clinical trials is extremely high, even when preceded by encouraging preclinical studies and phase II trial results of the same therapy. Thus there is considerable effort being made to improve the predictive clinical potential of preclinical models,...
שמור ב:
| הוצא לאור ב: | Cancer Res |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2013
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334448/ https://ncbi.nlm.nih.gov/pubmed/23610448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-12-4183 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|